Atlas Trials

Proglumide and Chemotherapy for Metastatic Pancreatic Cancer

Clinical trial NCT05827055 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05827055
Sponsor
Georgetown University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2024-01-31
Primary completion
2027-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.